Correspondence 0001104659-24-123192 from Blaize Holdings, Inc. (BZAI)
Blaize Holdings, Inc.
Date: Nov. 26, 2024 · CIK: 0001871638 · Accession: 0001104659-24-123192
AI Filing Summary & Sentiment
File numbers found in text: 333-280889
Referenced dates: November 26, 2024
Show Raw Text
CORRESP
1
filename1.htm
Norton Rose Fulbright US LLP
1301 Avenue of the Americas
New York, NY 10019-6022 United States
Direct line +1 212-318-3168
Rajiv.Khanna @nortonrosefulbright.com
Tel +1 212 318 3000
Fax +1 212 408 5100
nortonrosefulbright.com
November 26, 2024
VIA EDGAR
Securities and Exchange
Commission Division of
Corporation Finance Office of
Manufacturing
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Sarah Sidwell
Geoffrey Kruczek
Re:
BurTech Acquisition Corp.
Amendment No. 5 to Registration Statement on Form S-4
Filed on November 22, 2024
File No. 333-280889
SEC Comment Letter dated November 26, 2024
Dear Ms. Sidwell and Mr. Kruczek:
On behalf of BurTech Acquisition
Corp. (“BurTech”, the “Registrant”, or the “Company”) and Blaize, Inc. (the “Co-Registrant”),
we are submitting via EDGAR for review by the Securities and Exchange Commission (the “Commission”) this response letter and
the accompanying Amendment No. 6 (including certain exhibits) (“Amendment No. 6”) to the above-referenced Amendment
No. 5 to Registration Statement on Form S-4 filed by the Registrant and Co-Registrant on November 22, 2024 (the “Registration
Statement”). This letter and Amendment No. 6 reflect the Registrant’s respectful acknowledgement and response to the
comments received from the staff of the Commission (the “Staff”) regarding the Registration Statement contained in the Staff’s
letter dated November 26, 2024 (the “Comment Letter”), and certain other updated information. For your convenience, we
are providing to the Staff a supplemental typeset copy of Amendment No. 6 marked to indicate the changes from the Registration Statement.
The Staff’s comments
as reflected in the Comment Letter are reproduced in italics in this letter, and the corresponding responses of the Registrant and Co-Registrant
are shown below each comment. All references to page numbers in the responses herein are to the page numbers in Amendment No. 6.
Amendment No. 5 to Registration Statement on Form S-4
filed on November 22, 2024
General
1. Please revise your disclosure to reflect the annual shareholders meeting being called on December 9,
2024 to extend the deadline to consummate a business combination to May 15, 2025. Please state the date by which, pursuant to your
charter, you need to complete a business combination before having to liquidate and dissolve the SPAC. Also, considering the December 23,
2024 meeting date related to the transactions in this document, the hypothetical risk presented on page 80 appears to now involve
a near-certain event that will occur. As such, please revise clearly throughout, including page 80, to state that the SPAC will be
subject to immediate suspension and delisting because it will not have completed a business combination within 36 months of its IPO. Discuss
the effects such suspension and delisting may have on the ability to complete this business combination, such as any termination rights
available.
Response:
The Company respectfully advises the Staff that it has revised the disclosure on the cover page and pages 80, 264 and 269 of
Amendment No. 6 in response to the comment.
Ms. Sidwell and Mr. Kruczek
Securities and Exchange Commission
November 26, 2024
Page 2
Annex B, page B-1
2. Please update Annex B to reflect the final form of the Certificate of Incorporation, consistent with
your revisions made in response to prior comment one.
Response:
The Company respectfully advises the Staff that it updated Annex B in response to the comment.
* * *
We hope that the foregoing has been helpful to
the Staff’s understanding of the Registrant and Co-Registrant’s disclosure and that the disclosure modifications in Amendment
No. 6 are satisfactory to the Staff. If you have any questions or comments about this letter or need any further information, please
call the undersigned at (212) 318-3168.
Very Truly Yours
By:
/s/ Rajiv Khanna
Rajiv Khanna
cc: Shahal Khan (BurTech Acquisition Corp.)
Dinakar Munagala (Blaize, Inc.)
Ryan Lynch (Latham & Watkins LLP)
Lee McIntyre (Norton Rose Fulbright US LLP)